Literature DB >> 6362110

Earlier trabeculectomy.

J L Jay.   

Abstract

This is a preliminary report of a collaborative, prospective, randomised trial of management of primary open angle glaucoma where conventional management using medical therapy followed by trabeculectomy only in unsuccessful cases (Group A) was compared with trabeculectomy as the primary form of treatment supplemented where necessary by medical therapy (Group B). Using one eye of each patient 40 eyes were available at one year and 14 eyes at two years after entry to the trial. The two groups were comparable for age, sex, intraocular pressure before treatment, visual acuity, visual fields and other features. Seven of the 22 eyes in Group A (31 per cent) had required operation in the first year and two of the 18 eyes in Group B (11 per cent) had required supplementary medical therapy in the same period. Trabeculectomy was more effective in lowering intraocular pressure than medical treatment. No statistically significant differences in visual function or disc appearances are yet detectable but there is a trend in favour of trabeculectomy as a primary procedure (Group B).

Entities:  

Mesh:

Year:  1983        PMID: 6362110

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  4 in total

1.  Early trabeculectomy versus conventional management in primary open angle glaucoma.

Authors:  J L Jay; S B Murray
Journal:  Br J Ophthalmol       Date:  1988-12       Impact factor: 4.638

2.  Raised intraocular pressure with topical steroids after trabeculectomy.

Authors:  R Thomas; J L Jay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

3.  Glaucoma in a suburban tertiary care hospital in Nigeria.

Authors:  Malachi Epo Enock; Afekhide Ernest Omoti; Razak Onozutu Momoh
Journal:  J Ophthalmic Vis Res       Date:  2010-04

4.  Cost Analysis of Medical versus Surgical Management of Glaucoma in Nigeria.

Authors:  Afekhide E Omoti; Omolabake T Edema; Benedicta A Akpe; Patricia Musa
Journal:  J Ophthalmic Vis Res       Date:  2010-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.